Dr Jarosław Długołęcki

Dr Jarosław Długołęcki

Mr Jarosław Długołęcki

We are pleased to welcome a new member of the BRG medical expert team. Mr Jarosław Długołęcki, (M.D.) - doctor with extensive knowledge and 16-years’ experience in clinical studies at the international level. He cooperated with global pharmaceutical companies and conducted research in renowned centre's such as PAREXEL Intl Westend Hospital Berlin, Germany, Department of Clinical Pharmacology. In his professional path he leaded and manage as Global Study Leader, oncological study team ( phase III, lung cancer , 760 randomized patients) in 34 countries located in Europe, Asia, North and South America and Australia (Data Management, Medical Writing, Medical Monitoring, being responsible for the whole study processes. This study was inspected by EMEA, FDA, CFDA, PMDA successfully and obtained fast registration in EU, USA, Japan, China and other countries. He cooperates with the emergency department of Warsaw hospital, gaining extensive, practical, experience with severe forms of respiratory failure, requiring the use of various methods of supporting ventilation, circulatory failure and multi-organ failure.

He works part time as GP at one of facility doctor's center

Dr Długołęcki as the main investigator successfully performed 45 clinical trials in the following medical areas:

  • Rheumatoid Arthritis
  • Osteoarthritis
  • Lung cancer
  • Breast cancer
  • Skin cancer
  • Cervical cancer of the uterus
  • Hepatitis B
  • Nephrology
  • Hepatitis C
  • Multiple sclerosis
  • Asthma
  • COPD
  • Respiratory infections
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Anemia
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Heart failure

His substantial practice covers all phases of clinical trials. Currently, Dr. Długołęcki conducts specialized training for clinical research centres, CROs and pharmaceutical companies in the field of good practices, effective conducting of clinical trials as well GCP regulation, EU’s , FDA's Japan's and China's regulation as well as  Polish law regarding clinical study.

Dr Dlugolecki's motto is ,, Who is bored with clinical trials is bored with life”.

Go back

News

Medical Guide Where to Treat 2022

On 29th of April, a special thematic supplement was published in the Polska The Times and Miasto.pl newspaper - Medical Guide Where to Treat 2022...

Read more …

BRG Support for Ukraine

We are deeply moved and concerned by the events in Ukraine. As a clinical site, focused on the development of medicine and helping other people,...

Read more …

Completion of a single-center phase I study of the safety and pharmacokinetics of CPL207280

We have just completed a phase I study of safety and pharmacokinetics (part B) of an innovative therapy that could be used...

Read more …

GcLP quality certificate for laboratory procedures

The BRG Clinical Site received the GcLP quality certificate for laboratory procedures and is in the process of obtaining GMP certification for pharmaceutical procedures.

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2022 © Bio Research Group. All rights reserved.

 

scroll to top ▲